Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/324276 
Year of Publication: 
2025
Series/Report no.: 
Research Paper No. 222
Publisher: 
South Centre, Geneva
Abstract: 
This paper proposes a framework for designing an Independent Panel on Evidence for Action on Antimicrobial Resistance (IPEA), responding to the 2025 United Nations General Assembly mandate. Through a comparative analysis of selected international scientific advisory bodies, we identify the panel's mandate as the foundational element that will critically shape its composition, scope, deliverables, and governance structure. Our framework addresses key domains of credibility, scientific integrity, authority, policy relevance, and sustainability while establishing equity as a fundamental design principle - not merely ensuring low and middle-income country (LMIC) participation but designing the IPEA to address existing imbalances in antimicrobial resistance (AMR) evidence production and dissemination. We analyse potential mandate options, from evidence synthesis to policy recommendations, highlighting the importance of defining a unique and complementary role for IPEA within the existing AMR governance landscape to avoid duplication and maximize impact on global AMR response.
Subjects: 
Antimicrobial Resistance (AMR)
Biodiversity
Climate Change
Global Health
Health
Independent Panel on Evidence for Action against AMR
Low- and Middle-income Countries (LMICs)
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.